| 24小時(shí)熱門版塊排行榜 |
| 2 | 1/1 | 返回列表 |
| 查看: 284 | 回復(fù): 1 | |||
myIDname木蟲 (著名寫手)
人民大會(huì)堂首席清潔工
|
[交流]
2012/11/30 news of the week@SCIENCE 之六:神經(jīng)學(xué)專家卷入內(nèi)部交易案件
|
|
本周第六條報(bào)導(dǎo),原文鏈接:http://www.sciencemag.org/content/338/6111/1132.1.full.pdf New York 6 Neurologist Implicated In Insider Trading Case 神經(jīng)學(xué)專家卷入內(nèi)部交易案件 Federal authorities filed charges last week in what they said is the most lucrative insider trading case in history. According to the Securities and Exchange Commission (SEC), Sidney Gilman, a neurology professor at the University of Michigan, Ann Arbor, fed secret information about clinical trials of an Alzheimer’s drug to Mathew Martoma, a formerportfolio manager at a division of the hedge fund SAC Capital Advisors, allowing Martoma to make more than $276 million inillicit profits and avoid losses with well-timed stock purchases and sales. 聯(lián)邦政府上周發(fā)出了一份指控,里面涉及了到史上涉案金額最高的內(nèi)部交易。根據(jù)安全交易委員會(huì)(SEC)提供的信息,Ann Arbor密西根大學(xué)的神經(jīng)學(xué)教授Sidney Gilman向Mathew Martoma泄露了Alzheimer公司一種藥物的臨床試驗(yàn)機(jī)密信息,使得這位SCA咨詢公司的前任對(duì)沖基金部負(fù)責(zé)人Martoma通過把握買賣股票的有利時(shí)機(jī)避免了損失,同時(shí)獲取了超過2.76億美元的非法收入。 The drug, bapineuzumab, was a oncepromising Alzheimer’s therapy originally developed by Elan and Wyeth. Based on information from Gilman, Martoma allegedly invested more than $700 million in the companies’ stocks when the prospects for bapineuzumab looked good, and later unloaded more than $960 million worth of stock in just over a week when the news turned bad. Bapineuzumab是Alzheimer公司的治療藥物,最初由Elan和Wyeth研發(fā),并曾被一度看好。根據(jù)Gilman交待的情況,Martoma涉嫌在bapineuzumab市場(chǎng)前景光明的時(shí)候購(gòu)買了7億多美元公司股票,而后僅僅在一個(gè)星期之后,當(dāng)情況逆轉(zhuǎn)的時(shí)候又拋出了價(jià)值超過9.6億美元的公司股票。 SEC alleges that Gilman, a former chair of the Michigan neurology department who served as chair of the trial’s Safety and Monitoring Committee, received nearly $108,000 for his consultations with Martoma from a New York–based firm that connects investors with technical experts. Gilman is cooperating with authorities in exchange for nonprosecution. Gilman之前擔(dān)任密西根大學(xué)神經(jīng)學(xué)系系主任,現(xiàn)在是臨床試驗(yàn)安全監(jiān)管委員會(huì)主席。SEC指控他通過紐約一家聯(lián)系投資人和技術(shù)專家的公司,收取了Martoma將近10.8萬(wàn)美元的咨詢費(fèi)。為了免于被起訴,Gilman目前正在配合政府調(diào)查。 *************************************************************** Science的原文和本翻譯僅用于網(wǎng)友交流學(xué)習(xí)之用,若您有其它用途,比如商業(yè)用途等,請(qǐng)聯(lián)系Science雜志社了解原文使用權(quán)等相關(guān)事宜。謝謝! |

木蟲 (著名寫手)
人民大會(huì)堂首席清潔工

| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料與化工328分調(diào)劑 +7 | 。,。,。,。i 2026-03-23 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 各位老師好,我的一志愿為北京科技大學(xué)085601材料專碩 +9 | Koxui 2026-03-28 | 9/450 |
|
|
[考研] 330分求調(diào)劑 +5 | qzenlc 2026-03-29 | 5/250 |
|
|
[碩博家園] 招收生物學(xué)/細(xì)胞生物學(xué)調(diào)劑 +4 | IceGuo 2026-03-26 | 5/250 |
|
|
[考研] 311(085601)求調(diào)劑 +4 | liziyeyeye 2026-03-28 | 4/200 |
|
|
[考研] 320分,材料與化工專業(yè),求調(diào)劑 +9 | 一定上岸aaa 2026-03-27 | 13/650 |
|
|
[考研] 346求調(diào)劑 一志愿070303有機(jī)化學(xué) +3 | 蘿卜燉青菜 2026-03-28 | 3/150 |
|
|
[考研] 322求調(diào)劑 +5 | 舊吢 2026-03-24 | 5/250 |
|
|
[考研] 0703本科鄭州大學(xué)求調(diào)劑 +3 | nhj_ 2026-03-25 | 3/150 |
|
|
[考研] 311求調(diào)劑 +9 | lin0039 2026-03-26 | 9/450 |
|
|
[考研] 340求調(diào)劑 +5 | jhx777 2026-03-27 | 5/250 |
|
|
[考研] 考研調(diào)劑 +9 | 小蠟新筆 2026-03-26 | 9/450 |
|
|
[考研] 求調(diào)劑323材料與化工 +7 | 1124361 2026-03-24 | 7/350 |
|
|
[考研] 342求調(diào)劑 +3 | 加油a李zs 2026-03-26 | 3/150 |
|
|
[考研] 327求調(diào)劑 +7 | prayer13 2026-03-23 | 7/350 |
|
|
[考研] 生物學(xué) 296 求調(diào)劑 +4 | 朵朵- 2026-03-26 | 6/300 |
|
|
[考研] 一志愿南航 335分 | 0856材料化工 | GPA 4.07 | 有科研經(jīng)歷 +6 | cccchenso 2026-03-23 | 6/300 |
|
|
[考研] 考研一志愿蘇州大學(xué)初始315(英一)求調(diào)劑 +3 | sbdksD 2026-03-24 | 4/200 |
|
|
[考研] 上海電力大學(xué)材料防護(hù)與新材料重點(diǎn)實(shí)驗(yàn)室招收調(diào)劑研究生(材料、化學(xué)、電化學(xué),環(huán)境) +4 | 我愛學(xué)電池 2026-03-23 | 4/200 |
|
|
[考研]
|
黃粱一夢(mèng)千年 2026-03-24 | 3/150 |
|